MedPath

Sodium Bicarbonate

Sodium Bicarbonate Injection, USP

Approved
Approval ID

e4ef2cb3-3d80-4d71-b50f-15571caac73a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 19, 2024

Manufacturers
FDA

Hospira, Inc.

DUNS: 141588017

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SODIUM BICARBONATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-4900
Application NumberANDA202495
Product Classification
M
Marketing Category
C73584
G
Generic Name
SODIUM BICARBONATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 19, 2024
FDA Product Classification

INGREDIENTS (2)

SODIUM BICARBONATEActive
Quantity: 84 mg in 1 mL
Code: 8MDF5V39QO
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Bicarbonate - FDA Drug Approval Details